Prozac, a common medication used to combat depression, has been found to be less effective on patients with a specific gene set. People who have taken Prozac for two months but have shown no sign of improvement should opt for another treatment, says a medical report released by the Taipei Veterans General Hospital (TVGH). Tsai Shih-jen (蔡世仁), section chief of General Psychiatry at TVGH, said those with major depression carry genes that mitigate serotonin reuptake transporters, enhance monoamine oxidase, disrupt brain-derived neurotrophic factors, or generate serotonin 1A receptors that are more likely to be "Prozac-resistant."
Fri, Nov 17, 2006 - Page 3 News List
Taiwan Quick Take: Limitations found for Prozac
STAFF WRITER WITH AGENCIES
This story has been viewed 1973 times.
Listing from 2014-12-16 to 2014-12-23
- Most read
- Most e-mailed
1HK says Occupy protest ‘over’ as last site cleared
2US jury clears Apple Inc in iPod antitrust lawsuit
3Brent crude spirals below US$60 in volatile market
4BlackBerry reduces losses as revenue falls
5KMT’s Alex Tsai surfaces, ignites furor